Formaggio N et al. [25] mentioned that OCT4 contributes to the dedifferentiation of PCa into an AR-negative state, promoting neuroendocrine differentiation and reducing sensitivity to AR-targeted therapies. This evidence concerns the gene POU5F1 and posterior cortical atrophy.